Devyser wins tender in Italy worth approximately SEK 5.7 million – doubling test volumes compared with previous agreement
Devyser Diagnostics AB, through its Italian subsidiary, has been awarded a renewed tender by...
News | August 18, 2022
On September 1, Camilla Wiberg will take up the newly established position as Chief HR Officer (CHRO) and become a member of the Devyser group management. In Devyser’s current growth phase, HR is an important, central function needed to support and develop the organization. Camilla will lead this work in her new role.
Camilla Wiberg has nearly 20 years’ experience working in strategic and operational HR in a number of industries. For the past five years she has run her own company, where she has held various positions including interim HR Manager and organization development roles. She previously worked in HR at companies such as Orkla Care AB and Avanade.
“Camilla has acted as Devyser’s HR Manager on a consultancy basis since autumn 2020 and knows our company and our employees well. We are very pleased that she has chosen to continue to work with us in this new role and we will benefit greatly from her extensive experience working with global growth companies”, says Fredrik Alpsten, Devyser’s CEO.
Following Camilla Wiberg’s appointment, the company’s group management team will comprise Fredrik Alpsten, CEO, Sabina Berlin, CFO, Theis Kipling, CCO, Göran Rydin, COO, Ulf Klangby, Deputy CEO, and Camilla Wiberg, CHRO.
This information was submitted for publication by the contact persons below on 18 August 2022 at 10.30 am CET.
For more information, please contact:
Fredrik Alpsten, CEO
E-mail: fredrik.alpsten@devyser.com
Tel: +46 706 673 106
Sabina Berlin, CFO
E-mail: sabina.berlin@devyser.com
Tel: +46 739 519 502
Link to the official press release:
https://investors.devyser.com/en/press/devyser-appoints-camilla-wiberg-chief-hr-officer-2044197
Devyser Diagnostics AB, through its Italian subsidiary, has been awarded a renewed tender by...
Read More
Devyser announced that One Lambda™ Devyser Accept cfDNA, its test for monitoring kidney transplant...
Read More
Devyser, a global leader in advanced molecular diagnostics, today announced the first commercial...
Read More
One Lambda™ Devyser Chimerism Plus is a next generation solution for chimerism analysis following...
Read More